Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 6
Submit an article Journal homepage
92
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Dynamics of Fibrosis in Chronic Idiopathic (Primary) Myelofibrosis During Therapy: A follow-up Study on 309 Patients

J. Thiele Institutes of Pathology, University of Cologne, Joseph-Stelzmannstr.9, D-50924 Cologne, Germany
,
H.M. Kvasnicka Institutes of Pathology, University of Cologne, Joseph-Stelzmannstr.9, D-50924 Cologne, Germany
,
A. Schmitt-Graeff University of Freiburg, Albertstr. 19 D-79104 Freiburg, Germany
&
V. Diehl First Clinic of Medicine University of Cologne, Cologne, Germany
Pages 949-953 | Published online: 01 Jul 2009

  • Smith, R.E., Chelmowski, M.K. and Szabo, E.J. (1988) "Myelofibrosis: a concise review of clinical and pathologic features and treatment", American Journal of Hematolology 29, 174-180.
  • Thiele, J., Zankovich, R., Steinberg, T., Fischer, R. and Diehl, V. (1989) "Agnogenic myeloid metaplasia (AMM)-correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients", Hematology Oncalology 7, 327-343.
  • Anger, B., Seidler, R., Haug, U., Popp, C. and Heimpel, H. (1990) "Idiopathic myelofibrosis: a retrospective study of 103 patients", Haematologica 75, 228 234.
  • Thiele, J., Kvasnicka, H.M., Werden, C., Zankovich, R., Diehl, V. and Fischer, R. (1996) "Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact", Leukemia and Lymphoma 22, 303-317.
  • Barosi, G. (1999) "Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines", Journal of Clinical Oncolology 17, 2954-2970.
  • Tefferi, A. (2000) "Myelofibrosis with myeloid metaplasia", New England Journal of Medicine 342, 1255 - 1265.
  • Anderson, J.E., Sale, G., Appelbaum, F.R., Chauncey, T.R. and Storb, R. (1997) "Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis", British Journal of Haematology 98, 1010-1016
  • Guardiola, P., Anderson, J.E., Bandini, G., Cervantes, F., Runde, V., Arcese, W., Bacigalupo, A., Przepiorka, D., O'Donnell, M.R., Polchi, P., Buzyn, A., Sutton, L., Cazals-Hatem, D., Sale, G., de Witte, T., Deeg, H.J. und Gluckman, E. (1999) "Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation. Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midolla Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study", Blood 93, 2831 -2838.
  • Thiele, J., Simon, K.G., Fischer, R. and Zankovich, R. (1988) "Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteomyelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients", Pathology Research and Practice 183, 434-445.
  • Hasselbalch, H. and Lisse, I. (1991) "A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis", European Journal of Haematology 46, 285-289.
  • Buhr, T., Georgii, A. and Choritz, H. (1993) "Myelofibrosis in chronic mycloproliferative disorders. Incidence among subtypes according to the Hanover Classification", Pathology Research and Practice 189, 121-132.
  • Georgii, A., Buesche, G. and Kreft, A. (1998) "The histopathology of chronic myeloproliferative diseases", Baillieres Clinical Haematology 11, 721-749.
  • Thiele, J., Kvasnicka, H.M., Zankovich, R. and Diehl, V. (2002) "Early stage idiopathic (primary) myelofibrosis-current issues of diagnostic features", Leukemia and Lymphoma 43, 1035-1041.
  • Georgii, A., Vykoupil, K.K. Buhr, T., Choritz, H., Doehler, U., Kaloutsi, V. and Werner, M. (1990) "Chronic myelopmliferative disorders in bone marrow biopsies", Pathology Research and Practice 186, 3-27
  • Thiele, J., Kvasnicka, H.M., Boeltken, B., Zankovich, R., Diehl, V. and Fischer, R. (1999) "Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF)-a clinicopathological study", Leukemia 13, 1741-1748.
  • Thiele, J., Imbert, M., Pierre, R., Vardiman, J.W., Brunning, R.D. and Flandrin, G. (2001) In: Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds, WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon), pp. 35-38.
  • Barosi, G., Ambrosetti, A., Finelli, C., Grossi, A., Leoni, P., Liberato, N.L., Petti, M.C., Pogliani, E., Ricetti, M., Rupoli, S., Visani, G. and Tura, S. (1999) "The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia", British Journal of Haematology 104, 730 -737.
  • Hasselbalch, H. and Jensen, B.A. (1990) "Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance", European Journal of Haematology 44, 172-178.
  • Visani, G., Finelli, C., Castelli. U., Petti, M.C., Ricci, P., Vianelli, N., Gianni, I., Zuffa, E., Aloe Spiriti, M.A. and Latagliata, R. (1990) "Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients", British Journal of Haematology 75, 4-9.
  • Rupoli, S., Da Lio, L., Sisti, S., Campanati, G., Salvi, A., Brianzoni, M.F., D'Amico, S., Cinciripini, A. and Leoni, P. (1994) "Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival", Annals of Hematology 68, 205-212.
  • Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. and Bauters, F. (1996) "Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system", Blood 88, 1013-1018.
  • Cervantes, F., Pereira, A., Esteve, J., Rafel, M., Cobo, F. Rozman, C. and Montserrat, H. (1997) "Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis", British Journal of Haematology 97, 635-640.
  • Reilty, J.T., Snowden, J.A., Spearing, R.L., Fitzgerald, P.M., Jones, N., Watmore, A. and Potter, A. (1997) "Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases", British Journal of Haematology 98, 96-102.
  • Cervantes, F., Barosi, G., Demory, J.L., Reilly, J., Guarnone, R., Dupriez, B., Pereira, A. and Montserrat, E. (1998) "Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups", British Journal of Haematology 102, 684-690.
  • Okamura, T., Kinukawa, N., Niho, Y. and Mizoguchi, H. (2001) "Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients", International Journal of Hematology 73, 194-198.
  • Charbord, P., Necl, H., Caillou, B. Kahn, H. and Parmentier, C. (1984) "Effect of alkylating agents on hematopoiesis in myelofibrosis, 4 case report", Nouvelle Revue Francais de Hematology 26, 361-369.
  • Manoharan, A. and Pitney, W.R. (1984) "Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis", Scandinavian Journal of Haematology 33, 453-459.
  • Loefvenberg, E., Wahlin, A. Roos, G. and Ost, A. (1990) "Reversal of myelofibrosis by hydroxyurea", European Journal of Haematology 44, 33 -38.
  • Bauermeister, D.E. (1971) "Quantitation of bone marrow reticulin a normal range", American Journal of Clinical Pathology 56, 24-31.
  • Cervantes, F., Pereira, A., Esteve, J., Cobo, F. Rozman, C. and Montserrat, E. (1998) 'The changing profile of idiopathicmyelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades", European Journal of Haematology 60, 101-105.
  • Lohmann, T.P and Beckman, E.N. (1983) "Progressive myelofibrosis in agnogenic myeloid metaplasia", Archives of Pathology Laboratory Medicine 107, 593-594.
  • Thiele, J., Laubert, A., Vykoupil, K.F. and Georgii, A. (1985) "Autopsy and clinical findings in acute leukemia and chronic myeloproliferative diseases-an evaluation of 104 patients", Pathology Research and Practice 179, 328-336.
  • Kreft, A., Reimann, J. and Choritz, H. (2000) "Fibre content and cellularity of the bone marrow of the iliac crest, vertebral column and sternum in chronic myeloproliferative disorders", Leukemia and Lymphoma 38, 165-173.
  • Wolf, B.C. and Neiman, R.S. (1985) "Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly", Blood 65, 803-809.
  • Barosi, G., Berzuini, C., Liberato, L.N., Costa, A., Polino, G. and Ascari, E. (1988) "A prognostic classification of myelofibrosis with myeloid metaplasia", British Journal of Haematology 70, 397-401.
  • Hasselbalch, H.C. (1993) "Idiopathic myelofibrosis-an update with particular reference to clinical aspects and prognosis", International Journal of Clinical laboratory Research 23, 124-138.
  • Carlo-Stella, C., Cazzola, M., Ganser, A., Barosi, G., Dezza, L. Meloni, E. Pedrazzoli, P., Hoelzer, D. and Ascari, E. (1987) "Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CRJ-GEMM, CFD-Mk. BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia", Blood 70, 1014-1019.
  • Le Bousse-Kerdiles, M.C. and Martyre, M.C. (1999) "Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia", Springer Seminars in Immunopathology 21, 491 -508.
  • Gilbert, H.S. (1998) "Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy", Cancer 83, 1205-1213.
  • Parmeggiani, L., Ferrant, A., Rodhain, J., Michaux, J.L. and Sokal, G. (1987) "Alpha Interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia", European Journal of Haematology 39, 228-232.
  • Barosi, G., Liberato, L.N., Costa, A., Buratti, A., Di Dio, F., Salvatore, S. and Ascari, E. (1990) "Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia", European Journal of Haematolagy Supplement 52, 12- 14.
  • Sacchi, S. (1995) "The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update", Leukemia and Lymphoma 19, 13-20.
  • Bachleitner-Hofmann, T. and Gisslinger, H. (1999) "The role of interferon-alpha in the treatment of idiopathic myelofibrosis", Annals in Hematology 78, 533-538.
  • van den Berg, H., Kluin, P.M. and Vossen, J.M. (1990) "Early reconstitution of haematopoiesis after allogeneic bone marrow transplantation: a prospective histopathological study of bone marrow biopsy specimens", Journal of Clinical Pathology 43, 365-369
  • Michelson, J.D., Gornet, M., Codd, T, Torres, J., Lanighan, K. and Jones, R. (1993) "Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma", Experimental Hematology 21, 475-482.
  • Rousselet, M.C., Kerjean, A., Guyetant, S., Francois, S., Saint-Andre, J.P. and Ifrah, N. (1996) "Histopathology of bone marrow after allogeneic bone marrow transplantation for chronic myeloid leukaemia", Pathology Research and Practice 192, 790-795.
  • Hurwitz, N. (1997) "Bone marrow trephine biopsy changes following chemotherapy and/or bone marrow transplantation", Current Diagnoses in Pathology 4, 196 202.
  • Thiele, J., Kvasnicka, H.M., Beelen, D.W., Leder, L.D. and Schaefer, D.W. (2001) "Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML, patients", Histology Histopathology 16, 213-226.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.